Peter J. Kuipers net worth and biography

Peter Kuipers Biography and Net Worth

CFO of Omnicell

Peter Kuipers joined Omnicell in August 2015. Mr. Kuipers had served as CFO at Quantcast Corporation, a world leader in applying the power of big data and analytics to digital audience measurement and advertising. Previously he served as Executive Vice President and CFO at The Weather Company (TWC), operating The Weather Channel,, and its professional services division WSI. Earlier, Mr. Kuipers served in senior financial leadership roles at Yahoo!, Altera Corporation, General Electric Company, and Akzo Nobel. He holds a Master’s Degree in Economics and Business Administration from the Maastricht University School of Business and Economics in the Netherlands.


What is Peter J. Kuipers' net worth?

The estimated net worth of Peter J. Kuipers is at least $3.07 million as of August 26th, 2022. Mr. Kuipers owns 61,326 shares of Omnicell stock worth more than $3,065,073 as of December 1st. This net worth approximation does not reflect any other investments that Mr. Kuipers may own. Additionally, Mr. Kuipers receives a salary of $1,180,000.00 as CFO at Omnicell. Learn More about Peter J. Kuipers' net worth.

How old is Peter J. Kuipers?

Mr. Kuipers is currently 50 years old. There are 5 older executives and no younger executives at Omnicell. The oldest executive at Omnicell is Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO, who is 65 years old. Learn More on Peter J. Kuipers' age.

What is Peter J. Kuipers' salary?

As the CFO of Omnicell, Inc., Mr. Kuipers earned a total compensation package of $4,176,126.00 in 2021. Mr. Kuipers earned a salary of $455,654.00, stock awards of $2,999,987.00, non-equity compensation of $697,151.00, and other compensation of $23,334.00.The highest earning executive at Omnicell is Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO, who commands a salary of $2,440,000.00 per year. Learn More on Peter J. Kuipers' salary.

How do I contact Peter J. Kuipers?

The corporate mailing address for Mr. Kuipers and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (650) 251-6100 and via email at [email protected] Learn More on Peter J. Kuipers' contact information.

Has Peter J. Kuipers been buying or selling shares of Omnicell?

Peter J. Kuipers has not been actively trading shares of Omnicell within the last three months. Most recently, Peter J. Kuipers sold 15,500 shares of the business's stock in a transaction on Friday, August 26th. The shares were sold at an average price of $108.29, for a transaction totalling $1,678,495.00. Following the completion of the sale, the chief financial officer now directly owns 61,326 shares of the company's stock, valued at $6,640,992.54. Learn More on Peter J. Kuipers' trading history.

Who are Omnicell's active insiders?

Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.

Are insiders buying or selling shares of Omnicell?

During the last year, insiders at the sold shares 8 times. They sold a total of 55,817 shares worth more than $6,738,669.58. The most recent insider tranaction occured on November, 28th when EVP Scott Peter Seidelmann sold 1,793 shares worth more than $92,267.78. Insiders at Omnicell own 2.8 % of the company. Learn More about insider trades at Omnicell.

Information on this page was last updated on 11/28/2022.

Peter J. Kuipers Insider Trading History at Omnicell

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/26/2022Sell15,500$108.29$1,678,495.0061,326View SEC Filing Icon  
8/22/2022Sell11,000$105.93$1,165,230.0061,326View SEC Filing Icon  
12/7/2021Sell8,517$181.15$1,542,854.55View SEC Filing Icon  
8/6/2021Sell11,500$157.88$1,815,620.0059,812View SEC Filing Icon  
5/18/2021Sell2,395$135.53$324,594.3571,849View SEC Filing Icon  
2/14/2020Sell11,267$89.79$1,011,663.9346,378View SEC Filing Icon  
5/8/2019Sell13,000$81.62$1,061,060.0055,829View SEC Filing Icon  
3/12/2019Sell24,504$83.97$2,057,600.8864,618View SEC Filing Icon  
3/9/2019Sell1,044$44.34$46,290.9656,873View SEC Filing Icon  
12/18/2018Sell2,429$64.18$155,893.2247,814View SEC Filing Icon  
12/10/2018Sell5,574$70.11$390,793.1451,542View SEC Filing Icon  
9/10/2018Sell5,574$68.87$383,881.3851,542View SEC Filing Icon  
8/14/2018Sell10$63.25$632.5051,552View SEC Filing Icon  
7/16/2018Sell2,818$53.06$149,523.0854,370View SEC Filing Icon  
6/6/2018Sell9,144$49.57$453,268.0856,970View SEC Filing Icon  
5/11/2018Sell3,456$47.62$164,574.7256,970View SEC Filing Icon  
4/12/2018Sell724$46.00$33,304.0056,970View SEC Filing Icon  
12/18/2017Sell1,926$51.69$99,554.9440,544View SEC Filing Icon  
11/17/2017Sell4,724$47.74$225,523.7640,544View SEC Filing Icon  
10/2/2017Sell3,532$50.96$179,990.7240,714View SEC Filing Icon  
8/9/2017Sell18,054$50.31$908,296.7444,236View SEC Filing Icon  
See Full Table

Peter J. Kuipers Buying and Selling Activity at Omnicell

This chart shows Peter J Kuipers's buying and selling at Omnicell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Omnicell Company Overview

Omnicell logo
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Read More

Today's Range

Now: $49.98
Low: $49.91
High: $52.46

50 Day Range

MA: $68.38
Low: $46.24
High: $90.03

2 Week Range

Now: $49.98
Low: $46.19
High: $185.28


6,899 shs

Average Volume

1,011,679 shs

Market Capitalization

$2.21 billion

P/E Ratio


Dividend Yield